Department of Urology Archive — Page 3 of 9
-
April 20, 2023
Overactive bladder and anxiety
Anxiety and psychological stress impact hypersensitivity mechanisms in women that could contribute to overactive bladder — a frequent and sudden urge to urinate that is difficult to control. -
April 3, 2023
More U.S. prostate cancer patients choosing active surveillance
A Vanderbilt study found the number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly increased since 2010, rising from 16% to 60% for low-risk patients and from 8% to 22% for patients with favorable intermediate-risk cancers. -
March 30, 2023
Urology fellowship program celebrated after 20 years
The urology fellowship training program focused on women’s urologic health and reconstruction, known as Female Pelvic Medicine and Reconstructive Surgery, is celebrating its 20th anniversary and graduating its 20th fellow in June at Vanderbilt University Medical Center. -
March 23, 2023
New MyHealth Bundles to help treat kidney stones, substance use disorder
Employees covered by Vanderbilt University Medical Center health plans and employees covered by the Metro Nashville Public Schools health plan can now enroll in two new MyHealth Bundles: MyUrologyHealth for the treatment of kidney stones and MyRecoveryHealth for the treatment of substance use disorder. -
March 23, 2023
E. coli uses serine to abide acidity
Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies. -
February 9, 2023
Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs
Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs. -
October 27, 2022
Study reveals pathways for aggressive prostate cancer subtype
Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.